Association of Apathy With Risk of Incident Dementia: A Systematic Review and Meta-analysis | Dementia and Cognitive Impairment | JAMA Psychiatry | JAMA Network
[Skip to Navigation]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 18.207.129.82. Please contact the publisher to request reinstatement.
1.
Commissaris  CJAM, Verhey  FRJ  Jr, Ponds  RWHM, Jolles  J, Kok  GJ.  Public education about normal forgetfulness and dementia: importance and effects.  Patient Educ Couns. 1994;24(2):109-115. doi:10.1016/0738-3991(94)90004-3PubMedGoogle ScholarCrossref
2.
Burmester  B, Leathem  J, Merrick  P.  Subjective cognitive complaints and objective cognitive function in aging: a systematic review and meta-analysis of recent cross-sectional findings.  Neuropsychol Rev. 2016;26(4):376-393. doi:10.1007/s11065-016-9332-2PubMedGoogle ScholarCrossref
3.
Mendonça  MD, Alves  L, Bugalho  P.  From subjective cognitive complaints to dementia: who is at risk?: a systematic review.  Am J Alzheimers Dis Other Demen. 2016;31(2):105-114. doi:10.1177/1533317515592331PubMedGoogle ScholarCrossref
4.
Albert  MS, DeKosky  ST, Dickson  D,  et al.  The diagnosis of mild cognitive impairment due to Alzheimer’s disease: recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer’s disease.  Alzheimers Dement. 2011;7(3):270-279. doi:10.1016/j.jalz.2011.03.008PubMedGoogle ScholarCrossref
5.
Mariani  E, Monastero  R, Mecocci  P.  Mild cognitive impairment: a systematic review.  J Alzheimers Dis. 2007;12(1):23-35. doi:10.3233/JAD-2007-12104PubMedGoogle ScholarCrossref
6.
Kales  HC, Gitlin  LN, Lyketsos  CG.  Assessment and management of behavioral and psychological symptoms of dementia.  BMJ. 2015;350(7):h369. doi:10.1136/bmj.h369PubMedGoogle ScholarCrossref
7.
Zhao  Q-F, Tan  L, Wang  H-F,  et al.  The prevalence of neuropsychiatric symptoms in Alzheimer’s disease: systematic review and meta-analysis.  J Affect Disord. 2016;190:264-271. doi:10.1016/j.jad.2015.09.069PubMedGoogle ScholarCrossref
8.
Robert  P, Onyike  CU, Leentjens  AF,  et al.  Proposed diagnostic criteria for apathy in Alzheimer’s disease and other neuropsychiatric disorders.  Eur Psychiatry. 2009;24(2):98-104. doi:10.1016/j.eurpsy.2008.09.001PubMedGoogle ScholarCrossref
9.
Monastero  R, Mangialasche  F, Camarda  C, Ercolani  S, Camarda  R.  A systematic review of neuropsychiatric symptoms in mild cognitive impairment.  J Alzheimers Dis. 2009;18(1):11-30. doi:10.3233/JAD-2009-1120PubMedGoogle ScholarCrossref
10.
Lanctôt  KL, Agüera-Ortiz  L, Brodaty  H,  et al.  Apathy associated with neurocognitive disorders: recent progress and future directions.  Alzheimers Dement. 2017;13(1):84-100. doi:10.1016/j.jalz.2016.05.008PubMedGoogle ScholarCrossref
11.
Padala  PR, Desouza  CV, Almeida  S,  et al.  The impact of apathy on glycemic control in diabetes: a cross-sectional study.  Diabetes Res Clin Pract. 2008;79(1):37-41. doi:10.1016/j.diabres.2007.06.012PubMedGoogle ScholarCrossref
12.
Hishikawa  N, Fukui  Y, Nakano  Y,  et al.  Factors related to continuous and discontinuous attendance at memory clinics.  Eur J Neurol. 2017;24(5):673-679. doi:10.1111/ene.13268PubMedGoogle ScholarCrossref
13.
Beishuizen  CRL, Coley  N, Moll van Charante  EP, van Gool  WA, Richard  E, Andrieu  S.  Determinants of dropout and nonadherence in a dementia prevention randomized controlled trial: the prevention of dementia by intensive vascular care trial.  J Am Geriatr Soc. 2017;65(7):1505-1513. doi:10.1111/jgs.14834PubMedGoogle ScholarCrossref
14.
Ellis  JM, Doyle  CJ, Selvarajah  S.  The relationship between apathy and participation in therapeutic activities in nursing home residents with dementia: evidence for an association and directions for further research.  Dementia (London). 2016;15(4):494-509. doi:10.1177/1471301214527300PubMedGoogle ScholarCrossref
15.
Richard  E, Schmand  B, Eikelenboom  P,  et al; Alzheimer’s Disease Neuroimaging Initiative.  Symptoms of apathy are associated with progression from mild cognitive impairment to Alzheimer’s disease in non-depressed subjects.  Dement Geriatr Cogn Disord. 2012;33(2-3):204-209. doi:10.1159/000338239PubMedGoogle ScholarCrossref
16.
Geda  YE, Roberts  RO, Mielke  MM,  et al.  Baseline neuropsychiatric symptoms and the risk of incident mild cognitive impairment: a population-based study.  Am J Psychiatry. 2014;171(5):572-581. doi:10.1176/appi.ajp.2014.13060821PubMedGoogle ScholarCrossref
17.
Geda  YE, Roberts  RO, Knopman  DS,  et al.  Prevalence of neuropsychiatric symptoms in mild cognitive impairment and normal cognitive aging: population-based study.  Arch Gen Psychiatry. 2008;65(10):1193-1198. doi:10.1001/archpsyc.65.10.1193PubMedGoogle ScholarCrossref
18.
Moher  D, Liberati  A, Tetzlaff  J, Altman  DG; PRISMA Group.  Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement.  BMJ. 2009;339:b2535. doi:10.1136/bmj.b2535PubMedGoogle ScholarCrossref
19.
Wolters Kluwer. Ovid: home. http://www.ovid.com/site/index.jsp. Accessed October 2, 2017.
20.
Clarke  DE, Ko  JY, Kuhl  EA, van Reekum  R, Salvador  R, Marin  RS.  Are the available apathy measures reliable and valid? a review of the psychometric evidence.  J Psychosom Res. 2011;70(1):73-97. doi:10.1016/j.jpsychores.2010.01.012PubMedGoogle ScholarCrossref
21.
Wells  G, Shae  BOD. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analysis (online). http://www.ohri.ca/programs/clinical_epidemiology/oxford.asp. Accessed June 8, 2018.
22.
Rosenberg  PB, Mielke  MM, Appleby  BS, Oh  ES, Geda  YE, Lyketsos  CG.  The association of neuropsychiatric symptoms in MCI with incident dementia and Alzheimer disease.  Am J Geriatr Psychiatry. 2013;21(7):685-695. doi:10.1016/j.jagp.2013.01.006PubMedGoogle ScholarCrossref
23.
Peters  ME, Rosenberg  PB, Steinberg  M,  et al; Cache County Investigators.  Neuropsychiatric symptoms as risk factors for progression from CIND to dementia: the Cache County Study.  Am J Geriatr Psychiatry. 2013;21(11):1116-1124. doi:10.1016/j.jagp.2013.01.049PubMedGoogle ScholarCrossref
24.
Ramakers  IH, Visser  PJ, Aalten  P, Kester  A, Jolles  J, Verhey  FR.  Affective symptoms as predictors of Alzheimer’s disease in subjects with mild cognitive impairment: a 10-year follow-up study.  Psychol Med. 2010;40(7):1193-1201. doi:10.1017/S0033291709991577PubMedGoogle ScholarCrossref
25.
Higgins  J, Green  S. Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0. Cochrane Collab. http://handbook.cochrane.org. Published 2011. Accessed June 8, 2018.
26.
Viechtbauer  W.  Conducting meta-analyses in R with the metafor package.  J Stat Softw. 2010;36(3):1-48. doi:10.18637/jss.v036.i03Google ScholarCrossref
27.
Schwarzer  G, Carpenter  JR, Rücker  G.  Meta-Analysis With R. Cham: Springer International Publishing; 2015, doi:10.1007/978-3-319-21416-0
28.
Robert  PH, Berr  C, Volteau  M,  et al; PréAL Study Group.  Importance of lack of interest in patients with mild cognitive impairment.  Am J Geriatr Psychiatry. 2008;16(9):770-776. doi:10.1097/JGP.0b013e31817e73dbPubMedGoogle ScholarCrossref
29.
Bartolini  M, Coccia  M, Luzzi  S, Provinciali  L, Ceravolo  MG.  Motivational symptoms of depression mask preclinical Alzheimer’s disease in elderly subjects.  Dement Geriatr Cogn Disord. 2005;19(1):31-36. doi:10.1159/000080968PubMedGoogle ScholarCrossref
30.
Burke  SL, Maramaldi  P, Cadet  T, Kukull  W.  Neuropsychiatric symptoms and Apolipoprotein E: associations with eventual Alzheimer’s disease development.  Arch Gerontol Geriatr. 2016;65:231-238. doi:10.1016/j.archger.2016.04.006PubMedGoogle ScholarCrossref
31.
Teng  E, Lu  PH, Cummings  JL.  Neuropsychiatric symptoms are associated with progression from mild cognitive impairment to Alzheimer’s disease.  Dement Geriatr Cogn Disord. 2007;24(4):253-259. doi:10.1159/000107100PubMedGoogle ScholarCrossref
32.
Vicini Chilovi  B, Conti  M, Zanetti  M, Mazzù  I, Rozzini  L, Padovani  A.  Differential impact of apathy and depression in the development of dementia in mild cognitive impairment patients.  Dement Geriatr Cogn Disord. 2009;27(4):390-398. doi:10.1159/000210045PubMedGoogle ScholarCrossref
33.
Somme  J, Fernández-Martínez  M, Molano  A, Zarranz  JJ.  Neuropsychiatric symptoms in amnestic mild cognitive impairment: increased risk and faster progression to dementia.  Curr Alzheimer Res. 2013;10(1):86-94. doi:10.1016/j.jalz.2011.05.428PubMedGoogle Scholar
34.
Sobów  T, Fendler  W, Magierski  R.  Body mass index and mild cognitive impairment-to-dementia progression in 24 months: a prospective study.  Eur J Clin Nutr. 2014;68(11):1216-1219. doi:10.1038/ejcn.2014.167PubMedGoogle ScholarCrossref
35.
Pink  A, Stokin  GB, Bartley  MM,  et al.  Neuropsychiatric symptoms, APOE ε4, and the risk of incident dementia: a population-based study.  Neurology. 2015;84(9):935-943. doi:10.1212/WNL.0000000000001307PubMedGoogle ScholarCrossref
36.
Palmer  K, Di Iulio  F, Varsi  AE,  et al.  Neuropsychiatric predictors of progression from amnestic-mild cognitive impairment to Alzheimer’s disease: the role of depression and apathy.  J Alzheimers Dis. 2010;20(1):175-183. doi:10.3233/JAD-2010-1352PubMedGoogle ScholarCrossref
37.
Brodaty  H, Heffernan  M, Draper  B,  et al.  Neuropsychiatric symptoms in older people with and without cognitive impairment.  J Alzheimers Dis. 2012;31(2):411-420. doi:10.3233/JAD-2012-120169PubMedGoogle ScholarCrossref
38.
van der Linde  RM, Stephan  BCM, Matthews  FE, Brayne  C, Savva  GM; Medical Research Council Cognitive Function and Ageing Study.  The presence of behavioural and psychological symptoms and progression to dementia in the cognitively impaired older population.  Int J Geriatr Psychiatry. 2013;28(7):700-709. doi:10.1002/gps.3873PubMedGoogle ScholarCrossref
39.
Chan  WC, Lam  LCW, Tam  CWC,  et al.  Neuropsychiatric symptoms are associated with increased risks of progression to dementia: a 2-year prospective study of 321 Chinese older persons with mild cognitive impairment.  Age Ageing. 2011;40(1):30-35. doi:10.1093/ageing/afq151PubMedGoogle ScholarCrossref
40.
McKhann  G, Drachman  D, Folstein  M, Katzman  R, Price  D, Stadlan  EM.  Clinical diagnosis of Alzheimer’s disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer’s Disease.  Neurology. 1984;34(7):939-944. doi:10.1212/WNL.34.7.939PubMedGoogle ScholarCrossref
41.
American Psychiatric Association.  Diagnostic and Statistical Manual of Mental Disorders.4th ed. Washington, DC: American Psychiatric Association; 1994.
42.
American Psychiatric Association.  Diagnostic and Statistical Manual of Mental Disorders. 3rd ed. Washington, DC: American Psychiatric Association; 1980.
43.
Morris  JC.  The Clinical Dementia Rating (CDR): current version and scoring rules.  Neurology. 1993;43(11):2412-2414. doi:10.1212/WNL.43.11.2412-aPubMedGoogle ScholarCrossref
44.
Palmer  K, Lupo  F, Perri  R,  et al.  Predicting disease progression in Alzheimer’s disease: the role of neuropsychiatric syndromes on functional and cognitive decline.  J Alzheimers Dis. 2011;24(1):35-45. doi:10.3233/JAD-2010-101836PubMedGoogle ScholarCrossref
45.
Cooper  C, Sommerlad  A, Lyketsos  CG, Livingston  G.  Modifiable predictors of dementia in mild cognitive impairment: a systematic review and meta-analysis.  Am J Psychiatry. 2015;172(4):323-334. doi:10.1176/appi.ajp.2014.14070878PubMedGoogle ScholarCrossref
46.
Mitchell  AJ, Beaumont  H, Ferguson  D, Yadegarfar  M, Stubbs  B.  Risk of dementia and mild cognitive impairment in older people with subjective memory complaints: meta-analysis.  Acta Psychiatr Scand. 2014;130(6):439-451. doi:10.1111/acps.12336PubMedGoogle ScholarCrossref
47.
Schneider  JA, Arvanitakis  Z, Leurgans  SE, Bennett  DA.  The neuropathology of probable Alzheimer disease and mild cognitive impairment.  Ann Neurol. 2009;66(2):200-208. doi:10.1002/ana.21706PubMedGoogle ScholarCrossref
48.
Pfeifer  L, Drobetz  R, Fankhauser  S, Mortby  ME, Maercker  A, Forstmeier  S.  Caregiver rating bias in mild cognitive impairment and mild Alzheimer’s disease: impact of caregiver burden and depression on dyadic rating discrepancy across domains.  Int Psychogeriatr. 2013;25(8):1345-1355. doi:10.1017/S1041610213000562PubMedGoogle ScholarCrossref
49.
Sink  KM, Covinsky  KE, Barnes  DE, Newcomer  RJ, Yaffe  K.  Caregiver characteristics are associated with neuropsychiatric symptoms of dementia.  J Am Geriatr Soc. 2006;54(5):796-803. doi:10.1111/j.1532-5415.2006.00697.xPubMedGoogle ScholarCrossref
50.
Pfeifer  L, Horn  AB, Maercker  A, Forstmeier  S.  Caregiver perception of apathy in persons with mild cognitive impairment or Alzheimer’s disease: a longitudinal study.  Aging Ment Health. 2017;21(5):494-500. doi:10.1080/13607863.2015.1118678PubMedGoogle ScholarCrossref
51.
Kim  G, DeCoster  J, Huang  C-H, Bryant  AN.  A meta-analysis of the factor structure of the Geriatric Depression Scale (GDS): the effects of language.  Int Psychogeriatr. 2013;25(1):71-81. doi:10.1017/S1041610212001421PubMedGoogle ScholarCrossref
52.
Ioannidis  JPA.  Why most discovered true associations are inflated.  Epidemiology. 2008;19(5):640-648. doi:10.1097/EDE.0b013e31818131e7PubMedGoogle ScholarCrossref
53.
Euser  SM, Schram  MT, Hofman  A, Westendorp  RGJ, Breteler  MMB.  Measuring cognitive function with age: the influence of selection by health and survival.  Epidemiology. 2008;19(3):440-447. doi:10.1097/EDE.0b013e31816a1d31PubMedGoogle ScholarCrossref
54.
Eurelings  LS, van Dalen  JW, Ter Riet  G, Moll van Charante  EP, Richard  E, van Gool  WA; ICARA Study Group.  Apathy and depressive symptoms in older people and incident myocardial infarction, stroke, and mortality: a systematic review and meta-analysis of individual participant data.  Clin Epidemiol. 2018;10:363-379. doi:10.2147/CLEP.S150915PubMedGoogle ScholarCrossref
55.
Ismail  Z, Elbayoumi  H, Fischer  CE,  et al.  Prevalence of depression in patients with mild cognitive impairment: a systematic review and meta-analysis.  JAMA Psychiatry. 2017;74(1):58-67. doi:10.1001/jamapsychiatry.2016.3162PubMedGoogle ScholarCrossref
56.
van Dalen  JW, Van Wanrooij  LL, Moll van Charante  EP, Richard  E, van Gool  WA.  Apathy is associated with incident dementia in community-dwelling older people.  Neurology. 2018;90(1):e82-e89. doi:10.1212/WNL.0000000000004767PubMedGoogle ScholarCrossref
57.
Ismail  Z, Smith  EE, Geda  Y,  et al; ISTAART Neuropsychiatric Symptoms Professional Interest Area.  Neuropsychiatric symptoms as early manifestations of emergent dementia: provisional diagnostic criteria for mild behavioral impairment.  Alzheimers Dement. 2016;12(2):195-202. doi:10.1016/j.jalz.2015.05.017PubMedGoogle ScholarCrossref
58.
Mortby  ME, Black  SE, Gauthier  S,  et al.  Dementia clinical trial implications of mild behavioral impairment.  Int Psychogeriatr. 2018;30(2):171-175. doi:10.1017/S1041610218000042PubMedGoogle ScholarCrossref
59.
Canevelli  M, Blasimme  A, Vanacore  N, Bruno  G, Cesari  M.  Mild behavioral impairment: ethical, methodological and clinical reflections.  Neurosci Biobehav Rev. 2016;69:402-403. doi:10.1016/j.neubiorev.2016.08.025PubMedGoogle ScholarCrossref
60.
Joosten-Weyn Banningh  L, Vernooij-Dassen  M, Rikkert  MO, Teunisse  JP.  Mild cognitive impairment: coping with an uncertain label.  Int J Geriatr Psychiatry. 2008;23(2):148-154. doi:10.1002/gps.1855PubMedGoogle ScholarCrossref
61.
Eurelings  LS, Ligthart  SA, van Dalen  JW, Moll van Charante  EP, van Gool  WA, Richard  E.  Apathy is an independent risk factor for incident cardiovascular disease in the older individual: a population-based cohort study.  Int J Geriatr Psychiatry. 2014;29(5):454-463. doi:10.1002/gps.4026PubMedGoogle ScholarCrossref
62.
Richard  E, Schmand  BA, Eikelenboom  P, Van Gool  WA; Alzheimer’s Disease Neuroimaging Initiative.  MRI and cerebrospinal fluid biomarkers for predicting progression to Alzheimer’s disease in patients with mild cognitive impairment: a diagnostic accuracy study.  BMJ Open. 2013;3(6):1-8. doi:10.1136/bmjopen-2012-002541PubMedGoogle ScholarCrossref
63.
Stephan  BCM, Tzourio  C, Auriacombe  S,  et al.  Usefulness of data from magnetic resonance imaging to improve prediction of dementia: population based cohort study.  BMJ. 2015;350:h2863. doi:10.1136/bmj.h2863PubMedGoogle ScholarCrossref
64.
Alegret  M, Cuberas-Borrós  G, Espinosa  A,  et al.  Cognitive, genetic, and brain perfusion factors associated with four year incidence of Alzheimer’s disease from mild cognitive impairment.  J Alzheimers Dis. 2014;41(3):739-748. doi:10.3233/JAD-132516PubMedGoogle ScholarCrossref
Original Investigation
October 2018

Association of Apathy With Risk of Incident Dementia: A Systematic Review and Meta-analysis

Author Affiliations
  • 1Department of Neurology, Academic Medical Center, University of Amsterdam, Amsterdam, the Netherlands
  • 2Donders Brain Institute, Department of Neurology, Radboud University Medical Center, University of Nijmegen, Nijmegen, the Netherlands
  • 3Department of General Practice, Academic Medical Center, University of Amsterdam, Amsterdam, the Netherlands
  • 4Institute of Public Health, University of Cambridge, Cambridge, United Kingdom
JAMA Psychiatry. 2018;75(10):1012-1021. doi:10.1001/jamapsychiatry.2018.1877
Key Points

Questions  What is the association between apathy in older people without dementia and incident dementia?

Findings  In this systematic review and meta-analysis of 16 studies including 7365 patients, memory clinic patients with apathy had an approximately doubled risk of incident dementia, depending on age and cognitive function. Adjustment for apathy definition and duration of follow-up explained 95% of heterogeneity in patients with mild cognitive impairment; results seem generalizable to memory clinic populations.

Meaning  Apathy is a relevant, noninvasive, cheap, and easily implementable prognostic factor prodromal to dementia. It has important clinical significance because patients are vulnerable and tend to withdraw from care, requiring an active caregiving approach from clinicians.

Abstract

Importance  Fear of dementia is pervasive in older people with cognitive concerns. Much research is devoted to finding prognostic markers for dementia risk. Studies suggest apathy in older people may be prodromal to dementia and could be a relevant, easily measurable predictor of increased dementia risk. However, evidence is fragmented and methods vary greatly between studies.

Objective  To systematically review and quantitatively synthesize the evidence for an association between apathy in dementia-free older individuals and incident dementia.

Data Sources  Two reviewers conducted a systematic search of Medline, Embase, and PsychINFO databases.

Study Selection  Inclusion criteria were (1) prospective cohort studies, (2) in general populations or memory clinic patients without dementia, (3) with clear definitions of apathy and dementia, and (4) reporting on the association between apathy and incident dementia.

Data Extraction and Synthesis  PRISMA and MOOSE guidelines were followed. Data were extracted by 1 reviewer and checked by a second.

Main Outcomes and Measures  Main outcomes were pooled crude risk ratios, maximally adjusted reported hazard ratios (HR), and odds ratios (OR) using DerSimonian-Laird random effects models.

Results  The mean age of the study populations ranged from 69.2 to 81.9 years (median, 71.6 years) and the percentage of women ranged from 35% to 70% (median, 53%). After screening 2031 titles and abstracts, 16 studies comprising 7365 participants were included. Apathy status was available for 7299 participants. Studies included populations with subjective cognitive concerns (n = 2), mild cognitive impairment (n = 11), cognitive impairment no dementia (n = 1), or mixed cognitive and no cognitive impairment (n = 2). Apathy was present in 1470 of 7299 participants (20.1%). Follow-up ranged from 1.2 to 5.4 years. In studies using validated apathy definitions (n = 12), the combined risk ratio of dementia for patients with apathy was 1.81 (95% CI, 1.32-2.50; I2 = 76%; n = 12), the hazard ratio was 2.39 (95% CI, 1.27-4.51; I2 = 90%; n = 7), and the odds ratio was 17.14 (95% CI, 1.91-154.0; I2 = 60%; n = 2). Subgroup analyses, meta-regression, and individual study results suggested the association between apathy and dementia weakened with increasing follow-up time, age, and cognitive impairment. Meta-regression adjusting for apathy definition and follow-up time explained 95% of heterogeneity in mild cognitive impairment.

Conclusions and Relevance  Apathy was associated with an approximately 2-fold increased risk of dementia in memory clinic patients. Moderate publication bias may have inflated some of these estimates. Apathy deserves more attention as a relevant, cheap, noninvasive, and easily measureable marker of increased risk of incident dementia with high clinical relevance, particularly because these vulnerable patients may forgo health care.

×